Lung cancer |
exo-miR-4443 |
Target METTL3/FSP1 |
Induce ferroptosis and increase cisplatin resistance of NSCLC |
67
|
miR-324-3p |
Target GPX |
Induce ferroptosis and reduce cisplatin resistance |
88
|
miR-27a-3p |
Target SLC7A11 |
Induce ferroptosis and inhibit lung cancer |
86
|
lncRNA P53RRA |
Interact with G3BP1 |
Induce ferroptosis and inhibit lung cancer |
77
|
LINC00336 |
Sponge with miR-6825 as ceRNA |
Inhibit ferroptosis and promoting lung cancer |
82
|
lncRNA mir503HG |
Sponge with miR-1273c as ceRNA |
Induce ferroptosis and inhibit NCSLC |
103
|
lncRNA NEAT1 |
Upregulate the expression of ACSL4 |
Induce ferroptosis and inhibit NCSLC |
96
|
lncRNA MT1DP |
target miR-365a-3p/NRF2 |
Induce ferroptosis and inhibit NCSLC |
72
|
lncRNA ASMTL-AS1 |
Stabilzing SAT1 and recruiting U2AF2 |
Induce ferroptosis and inhibit NCSLC |
104
|
circDTL |
Target miR-1287-5p/GPX4 |
Inhibit ferroptosis and promote lung cancer |
108
|
Gastrointestinal cancer |
miR-4715-3p |
DNA methylation and downregulate AURKA |
Induce ferroptosis and inhibit UGC |
75
|
exo-miR-522 |
Interact with ALOX15 |
Inhibit ferroptosis and promote chemotherapeutic resistance of GC |
80
|
miR-103a-3p |
Target GLS2 |
Induce ferroptosis and inhibit GC |
94
|
miR-139-5p |
Target SLC7A11 |
Induce ferroptosis and inhibit pancreatic carcinoma |
109
|
miR-375 |
Target SLC7A11 |
Induce ferroptosis and inhibit GC |
110
|
circ_0008035 |
Target miR-599/EIF4A1 |
Inhibit ferroptosis and promote GC |
68
|
circABCB10 |
Target miR-326/CCL5 |
Induce ferroptosis and inhibit rectal cancer |
71
|
circ_0007142 |
Target miR-874-3p/GDPD5 |
Induce ferroptosis and inhibit CRC |
70
|
Liver cancer |
miR-214-3p |
Target ATF4 |
Induce ferroptosis and inhibit HCC |
74
|
lncRNA GABPB1-AS1 |
Downregulation of GABPB1 and PRDX5 |
Induce ferroptosis and inhibit HCC |
69
|
lncRNA PVT1 |
Target miR-214-3p/GPX4 |
Inhibit ferroptosis and promote liver cancer |
90
|
circIL4R |
Target miR-541-3p/GPX4 |
Inhibit ferroptosis and promote HCC |
91
|
circcIARS |
Target ALKBH5 |
Induce ferroptosis and inhibit HCC after SF treatment |
126
|
circ_0097009 |
Target miR-1261/SLC7A11 |
Inhibit ferroptosis and promote HCC |
84
|
Breast cancer |
miR-324-3p |
Target GPX4 |
Induce ferroptosis and inhibit breast cancer |
89
|
miR-5096 |
Target SLC7A11 |
Induce ferroptosis and inhibit breast cancer |
127
|
lncRNA P53RRA |
Interact with G3BP1 |
Induce ferroptosis and inhibit breast cancer |
77
|
circGFRA1 |
Target miR-1228/AIFM2 |
Inhibit ferroptosis and promote breast cancer |
130
|
circRHOT1 |
Target miR-106a-5p/STAT3 |
Inhibit ferroptosis and promote breast cancer |
73
|
Urogenital cancer |
lncRNA RP11-89 |
Target miR-129-5p/PROM2 |
Inhibit ferroptosis and promote urogenital cancer |
132
|
Prostate cancer |
lncRNA OIP5-AS1 |
Target miR-128-3p/SLC7A11 |
Inhibit ferroptosis and promote prostate cancer |
135
|
Cervical cancer |
circEPSTI1 |
Target miR-375/409-3P/515-5p/SLC7A11 |
Inhibit ferroptosis and promote cervical cancer |
85
|
Ovarian cancer |
miR-424-5p |
Target ACSL4 |
Inhibit ferroptosis and promote ovarian cancer |
97
|
Acute myeloid leukemia |
LINC00618 |
Downregulate SLC7A11 |
Induce ferroptosis and inhibit Acute myeloid leukemia |
79
|
Glioma |
miR-18a |
Downregulate ALOXE3 |
Inhibit ferroptosis and promote glioma |
98
|
circTTBK2 |
Target miR-761/ITGB8 |
Inhibit ferroptosis and promote glioma |
76
|
Head and neck squamous cell carcinoma |
miR-125b-5p |
Target SLC7A11 |
Inhibit ferroptosis and promote tongue squamous cell carcinoma |
87
|
circFNDC3B |
Target miR-520d-5p/SLC7A11 |
Inhibit ferroptosis and promote orall squamous cell carcinoma |
78
|
circKIF4A |
Target miR-1231/GPX4 |
Inhibit ferroptosis and promote papillary thyroid cancer |
92
|
circ_0067934 |
Target miR-545-3p/SLC7A11 |
Inhibit ferroptosis and promote thyroid cancer |
144
|
Melanoma |
miR-137 |
Downregulate SLC1A5 |
Induce ferroptosis and inhibit melanoma |
81
|
miR-9 |
Downregulate GOT1 |
inhibit ferroptosis and promote melanoma |
95
|
Clinically relevant radioresistance |
miR-7-5p |
- |
Inhibit ferroptosis and promote CRR |
83
|